Apolipoprotein E genotype does not predict decline in intelligence in healthy older adults

Neurosci Lett. 2002 May 10;324(1):74-6. doi: 10.1016/s0304-3940(02)00135-0.

Abstract

There is evidence of a genetic influence on the decline in cognitive performance of older adults, although the mechanisms responsible are unknown. A group of 767 subjects of the Manchester University Age and Cognitive Performance longitudinal study volunteer group, followed up from 1985 to the present, were genotyped for apolipoprotein E (APOE). The data from this were related to cross-sectional and longitudinal trends in the Heim intelligence test score (AH4-1) using previously reported random-effects models (Neuropsychologia 39 (2001) 532). There were no significant differences in mean scores for presence compared with absence of the APOE4 or APOE2 genotypes (P=0.48 and P=0.51, respectively). This research does not demonstrate a link between intelligence and APOE genotype in older adults.

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Aging / genetics*
  • Aging / metabolism
  • Aging / pathology
  • Apolipoprotein E2
  • Apolipoprotein E4
  • Apolipoproteins E / genetics*
  • Apolipoproteins E / metabolism
  • Brain / metabolism*
  • Brain / physiopathology
  • Brain Chemistry / genetics*
  • Cognition Disorders / diagnosis
  • Cognition Disorders / genetics*
  • Cognition Disorders / metabolism
  • Cohort Studies
  • DNA Mutational Analysis
  • Female
  • Gene Frequency
  • Genetic Testing
  • Genotype
  • Humans
  • Intelligence / genetics*
  • Male
  • Middle Aged
  • Models, Statistical
  • Predictive Value of Tests
  • Sex Factors
  • Statistics as Topic

Substances

  • Apolipoprotein E2
  • Apolipoprotein E4
  • Apolipoproteins E